Vimarsana
Biggest News Aggregation in the World

Page 18 - Groupb Streptococcus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Groupb Streptococcus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Groupb Streptococcus Today - Breaking & Trending Today

Global Infectious Diseases Partnering Report 2022: Access - Vimarsana News

Global Infectious Diseases Partnering Report 2022: Access

Dublin, Oct. 19, 2022 (GLOBE NEWSWIRE) -- The "Global Infectious Diseases Partnering 2015-2022: Deal trends, players and financials" report has been...

"Virulence Mechanisms of Common Uropathogens and Their Intracellular Lo" by Samantha Ognenovska, Chinmoy Mukerjee et al. - Vimarsana News

"Virulence Mechanisms of Common Uropathogens and Their Intracellular Lo" by Samantha Ognenovska, Chinmoy Mukerjee et al.

A recurrent urinary tract infection (UTI) is a common debilitating condition whereby uropathogens are able to survive within the urinary tract. In this study, we aimed to determine if the common uropathogens Escherichia coli, Enterococcus faecalis, and Group B Streptococcus possessed virulence mechanisms that enable the invasion of urothelial cells. Urothelial cells were isolated from women with detrusor overactivity and recurrent UTIs; the intracellular localisation of the uropathogens was determined by confocal microscopy. Uropathogens were also isolated from women with acute UTIs and their ...

Source: uow.edu.au
Maternal Vaccine Candidate for GBS Prevention in Infants Gets Breakthrough Tx Status - Vimarsana News

Maternal Vaccine Candidate for GBS Prevention in Infants Gets Breakthrough Tx Status

The FDA has granted Breakthrough Therapy designation to an investigational Group B Streptococcus vaccine candidate to prevent invasive GBS disease.

Maternal Vaccine Candidate for GBS Prevention in Infants Gets Breakthrough Tx Status - Vimarsana News

Maternal Vaccine Candidate for GBS Prevention in Infants Gets Breakthrough Tx Status

The FDA has granted Breakthrough Therapy designation to an investigational Group B Streptococcus vaccine candidate to prevent invasive GBS disease.

Source: empr.com
Pfizer Says Its Group B Streptococcus Vaccine Candidate Got Breakthrough Therapy Designation - Vimarsana News

Pfizer Says Its Group B Streptococcus Vaccine Candidate Got Breakthrough Therapy Designation

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) on Wednesday said its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 received Breakthrough Therapy Designation from the Food and